| Sex and management of rheumatoid arthritis EG Favalli, M Biggioggero, C Crotti, A Becciolini, MG Raimondo, ... Clinical reviews in allergy & immunology 56, 333-345, 2019 | 210 | 2019 |
| Profile of sarilumab and its potential in the treatment of rheumatoid arthritis MG Raimondo, M Biggioggero, C Crotti, A Becciolini, EG Favalli Drug Design, Development and Therapy, 1593-1603, 2017 | 130 | 2017 |
| The X chromosome and the sex ratio of autoimmunity C Selmi, E Brunetta, MG Raimondo, PL Meroni Autoimmunity reviews 11 (6-7), A531-A537, 2012 | 100 | 2012 |
| The management of first-line biologic therapy failures in rheumatoid arthritis: current practice and future perspectives EG Favalli, MG Raimondo, A Becciolini, C Crotti, M Biggioggero, ... Autoimmunity reviews 16 (12), 1185-1195, 2017 | 99 | 2017 |
| Cutaneous manifestations of ANCA-associated small vessels vasculitis AV Marzano, MG Raimondo, E Berti, PL Meroni, F Ingegnoli Clinical reviews in allergy & immunology 53, 428-438, 2017 | 89 | 2017 |
| Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis C Selmi, F Cavaciocchi, A Lleo, C Cheroni, R De Francesco, SA Lombardi, ... Frontiers in immunology 5, 128, 2014 | 72 | 2014 |
| Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome CB Chighizola, F Pregnolato, L Andreoli, C Bodio, L Cesana, C Comerio, ... Journal of autoimmunity 90, 76-83, 2018 | 68 | 2018 |
| EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies F Pregnolato, M Gerosa, MG Raimondo, C Comerio, F Bartoli, PA Lonati, ... Rheumatology 60 (3), 1114-1124, 2021 | 55 | 2021 |
| Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: a multicenter study on 62 pregnancies MG Lazzaroni, M Fredi, L Andreoli, CB Chighizola, T Del Ross, M Gerosa, ... Frontiers in Immunology 10, 1948, 2019 | 44 | 2019 |
| Management of thrombotic antiphospholipid syndrome CB Chighizola, MG Raimondo, PL Meroni Seminars in thrombosis and hemostasis 44 (05), 419-426, 2018 | 38 | 2018 |
| Does APS impact women’s fertility? CB Chighizola, MG Raimondo, PL Meroni Current rheumatology reports 19, 1-9, 2017 | 32 | 2017 |
| Obesity is a major risk factor for hospitalization in community-managed COVID-19 pneumonia M Cottini, C Lombardi, A Berti, M Gregis, G Gregis, L Bello, M Mazid, ... Mayo Clinic Proceedings 96 (4), 921-931, 2021 | 27 | 2021 |
| Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date C Crotti, MG Raimondo, A Becciolini, M Biggioggero, EG Favalli Drug Design, Development and Therapy, 211-223, 2017 | 25 | 2017 |
| Real-world usage of digital health applications (DiGA) in rheumatology: results from a German patient survey H Labinsky, L Gupta, MG Raimondo, G Schett, J Knitza Rheumatology international 43 (4), 713-719, 2023 | 18 | 2023 |
| A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability A Becciolini, MG Raimondo, C Crotti, E Agape, M Biggioggero, EG Favalli Drug Design, Development and Therapy, 1969-1978, 2017 | 18 | 2017 |
| The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective … EG Favalli, A Becciolini, M Biggioggero, I Bertoldi, C Crotti, MG Raimondo, ... Drug Design, Development and Therapy, 1421-1429, 2018 | 16 | 2018 |
| Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome MG Raimondo, C Pericleous, A Radziszewska, MO Borghi, S Pierangeli, ... PLoS One 12 (10), e0186513, 2017 | 12 | 2017 |
| a minimal-invasive method to retrieve and identify entheseal tissue from psoriatic arthritis patients ML Pachowsky, MG Raimondo, C Xu, S Rauber, K Tascilar, H Labinsky, ... Annals of the Rheumatic Diseases 81 (8), 1131-1135, 2022 | 11 | 2022 |
| The potential of OMICs technologies for the treatment of immune-mediated inflammatory diseases CG Anchang, C Xu, MG Raimondo, R Atreya, A Maier, G Schett, ... International Journal of Molecular Sciences 22 (14), 7506, 2021 | 7 | 2021 |
| Recent developments in antiphospholipid antibodies and the antiphospholipid syndrome RT Urbanus Seminars in Thrombosis and Hemostasis 44 (05), 417-418, 2018 | 7 | 2018 |
